On June 1, 2026, eight insiders at Q32 Bio Inc. (QTTB) executed a series of significant stock purchases totaling approximately $60 million. The transactions, which occurred on May 28, 2026, involved directors and 10% owners associated with OrbiMed.
Specifically, OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC, and Diyong Xu each acquired shares at a price of $8.00 per share. These purchases included multiple tranches, with individual transactions ranging from 625,000 to 1,250,000 shares, representing individual investments of $5 million and $10 million respectively.
This cluster insider buying, where multiple executives purchase shares around the same time, is often interpreted as a strong bullish signal by market observers, suggesting confidence in the company's future prospects.